2.08
+0.03(+1.46%)
Currency In USD
| Previous Close | 2.05 |
| Open | 2.09 |
| Day High | 2.1 |
| Day Low | 2.05 |
| 52-Week High | 6.16 |
| 52-Week Low | 2 |
| Volume | 8,530 |
| Average Volume | 62,654 |
| Market Cap | 6.28M |
| PE | -0.83 |
| EPS | -2.51 |
| Moving Average 50 Days | 2.43 |
| Moving Average 200 Days | 2.86 |
| Change | 0.03 |
If you invested $1000 in Biomerica, Inc. (BMRA) 10 years ago, it would be worth $232.14 as of March 02, 2026 at a share price of $2.08. Whereas If you bought $1000 worth of Biomerica, Inc. (BMRA) shares 5 years ago, it would be worth $42 as of March 02, 2026 at a share price of $2.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
GlobeNewswire Inc.
Feb 26, 2026 1:19 PM GMT
Physician Interview Now AvailableKey Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company’s peer-
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
GlobeNewswire Inc.
Feb 18, 2026 1:19 PM GMT
Approval Marks Biomerica’s Strategic Entry into Southeast Asia’s Rapidly Growing Healthcare MarketSimple, FDA-Cleared At-Home Test Detects an Early Warning Sign of Colorectal Cancer in Minutes IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Biome
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
GlobeNewswire Inc.
Jan 14, 2026 10:17 PM GMT
Operating Expenses Decline 4% Year-to-DateBalance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagno